References:
1. World Health Organization. World malaria report 2022. World Health Organization; 2022.
2. Altahir O, AbdElbagi H, Abubakr M, Siddig EE, Ahmed A, Mohamed NS. Blood meal profile and positivity rate with malaria parasites among different malaria vectors in Sudan. Malaria Journal. 2022;21:124.
3. Ahmed A, Ali Y, Elduma A, Eldigail MH, Mhmoud RA, Mohamed NS, et al. Unique outbreak of Rift Valley fever in Sudan, 2019. Emerging infectious diseases. 2020;26:3030.
4. Ahmed A, Ali Y, Mohamed NS. Arboviral diseases: the emergence of a major yet ignored public health threat in Africa. The Lancet Planetary Health. 2020;4:e555.
5. Mohamed NS, Osman HA, Muneer MS, Samy AM, Ahmed A, Mohammed AO, et al. Identifying asymptomatic Leishmania infections in non-endemic villages in Gedaref state, Sudan. BMC Research Notes. 2019;12:1–7.
6. Yousif A, Siddig EE, Nouh M, Ahmed A. Rift Valley fever and malaria co-infection: A case report. Clinical Case Reports. 2023;11.
7. Mohamed NS, Ali Y, Muneer MS, Siddig EE, Sibley CH, Ahmed A. Malaria epidemic in humanitarian crisis settings the case of South Kordofan state, Sudan. The Journal of Infection in Developing Countries. 2021;15:168–71.
8. Mohamed NS, Ali Albsheer MM, Abdelbagi H, Siddig EE, Mohamed MA, Ahmed AE, et al. Genetic polymorphism of the N-terminal region in circumsporozoite surface protein of Plasmodium falciparum field isolates from Sudan. Malaria journal. 2019;18:1–10.
9. Mohamed NS, AbdElbagi H, Elsadig AR, Ahmed AE, Mohammed YO, Elssir LT, et al. Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS, S leading malaria vaccine candidate. Malaria Journal. 2021;20:1–12.
10. Mohamed NS, Abdelbagi H, Osman HA, Ahmed AE, Yousif AM, Edris YB, et al. A snapshot of Plasmodium falciparum malaria drug resistance markers in Sudan: a pilot study. BMC Research Notes. 2020;13:1–7.
11. Hemming-Schroeder E, Ahmed A. Anopheles stephensi in Africa: vector control opportunities for cobreeding An. stephensi and Aedes arbovirus vectors. Trends in Parasitology. 2022;
12. Elagali A, Ahmed A, Makki N, Ismail H, Ajak M, Alene KA, et al. Spatiotemporal mapping of malaria incidence in Sudan using routine surveillance data. Scientific Reports. 2022;12:1–13.
13. Ahmed A, Elduma A, Magboul B, Higazi T, Ali Y. The first outbreak of dengue fever in Greater Darfur, Western Sudan. Tropical medicine and infectious disease. 2019;4:43.
14. Lewallen S, Bronzan RN, Beare NA, Harding SP, Molyneux ME, Taylor TE. Using malarial retinopathy to improve the classification of children with cerebral malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008;102:1089–94.
15. Kochar A, Kalra P, Kochar S, Kochar SK, Kochar D. Retinal haemorrhage: An unusual presentation of vivax malaria. Journal of Vector Borne Diseases. 2013;50:321.
16. Maude RJ, Beare NA, Sayeed AA, Chang CC, Charunwatthana P, Faiz MA, et al. The spectrum of retinopathy in adults with Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009;103:665–71.
17. Beare NA, Taylor TE, Harding SP, Lewallen S, Molyneux ME. Malarial retinopathy: a newly established diagnostic sign in severe malaria. The American journal of tropical medicine and hygiene. 2006;75:790.
18. Mehta U, Allen E, Barnes KI. Establishing pharmacovigilance programs in resource-limited settings: the example of treating malaria. Expert review of clinical pharmacology. 2010;3:509–25.
19. Adeel AA, Elnour FAA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS, et al. High efficacy of artemether-lumefantrine and declining efficacy of artesunate+ sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010–2015): evidence from in vivo and molecular marker studies. Malaria journal. 2016;15:1–13.
20. World Health Organization. Compendium of WHO malaria guidance: prevention, diagnosis, treatment, surveillance and elimination. World Health Organization; 2019.